Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
75.9M
-
Shares change
-
+4M
-
Total reported value, excl. options
-
$1.16B
-
Value change
-
+$45.1M
-
Put/Call ratio
-
0.05
-
Number of buys
-
91
-
Number of sells
-
-46
-
Price
-
$15.35
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q1 2023
164 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q1 2023.
Avidity Biosciences, Inc. - Common Stock (RNA) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.9M shares
of 120M outstanding shares and own 63.19% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (6.86M shares), RA CAPITAL MANAGEMENT, L.P. (6.42M shares), RTW INVESTMENTS, LP (6.39M shares), BlackRock Inc. (5.63M shares), FMR LLC (5.42M shares), COWEN AND COMPANY, LLC (4.59M shares), STATE STREET CORP (4.38M shares), VANGUARD GROUP INC (3.48M shares), Cormorant Asset Management, LP (2.61M shares), and Avoro Capital Advisors LLC (2.51M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.